Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Giralt

Showing results (51-60 of 176) with videos related to

Pageof 18
Sort By:
Bone Marrow Transplantation|January 20, 2004
Outcomes of autologous stem cell transplantation in patients with multiple myeloma who received dexamethasone-based nonmyelosuppressive induction therapyA Anagnostopoulos, A Aleman, Y Yang, et al.
Transplantation Proceedings|December 1, 1992
T-cell-depleted autologous marrow fails to prevent acute graft-versus-host disease after allogeneic marrow transplantation for lymphoblastic lymphomaD Przepiorka, S Giralt, Y O Huh, et al.
Bone Marrow Transplantation|September 1, 2000
High-dose melphalan and allogeneic peripheral blood stem cell transplantation for treatment of early relapse after allogeneic transplantM de Lima, K van Besien, J Gajewski, et al.
The Science of the Total Environment|October 12, 2023
A ∼5000 year multiproxy record of summer climate in NE GreenlandJ Garcia-Oteyza, S Giralt, S Pla-Rabes, et al.
Clinical Pharmacy|July 1, 1993
Adverse effects of molgramostim in marrow transplant recipientsC Ippoliti, D Przepiorka, T Smith, et al.
Bone Marrow Transplantation|July 28, 2009
CR represents an early index of potential long survival in multiple myelomaM Wang, K Delasalle, L Feng, et al.
Bone Marrow Transplantation|May 11, 2004
CD8+ cell depletion of donor lymphocyte infusions using cd8 monoclonal antibody-coated high-density microparticles (CD8-HDM) after allogeneic hematopoietic stem cell transplantation: a pilot studyE P Alyea, C Canning, D Neuberg, et al.
British Journal of Haematology|September 30, 1998
Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow TransplantJ Bladé, D Samson, D Reece, et al.
Bone Marrow Transplantation|February 22, 2005
Outcome of unrelated transplants in patients with multiple myelomaK K Ballen, R King, M Carston, et al.
Bone Marrow Transplantation|March 2, 1997
Usefulness of detection of minimal residual disease by 'hypermetaphase' fluorescent in situ hybridization after allogeneic BMT for chronic myelogenous leukemiaD Seong, S Giralt, H Fischer, et al.
Pageof 18

Showing results (51-60 of 176) with videos related to

Sort By:
Pageof 18
Bone Marrow Transplantation|January 20, 2004
Outcomes of autologous stem cell transplantation in patients with multiple myeloma who received dexamethasone-based nonmyelosuppressive induction therapyA Anagnostopoulos, A Aleman, Y Yang, et al.
Transplantation Proceedings|December 1, 1992
T-cell-depleted autologous marrow fails to prevent acute graft-versus-host disease after allogeneic marrow transplantation for lymphoblastic lymphomaD Przepiorka, S Giralt, Y O Huh, et al.
Bone Marrow Transplantation|September 1, 2000
High-dose melphalan and allogeneic peripheral blood stem cell transplantation for treatment of early relapse after allogeneic transplantM de Lima, K van Besien, J Gajewski, et al.
The Science of the Total Environment|October 12, 2023
A ∼5000 year multiproxy record of summer climate in NE GreenlandJ Garcia-Oteyza, S Giralt, S Pla-Rabes, et al.
Clinical Pharmacy|July 1, 1993
Adverse effects of molgramostim in marrow transplant recipientsC Ippoliti, D Przepiorka, T Smith, et al.
Bone Marrow Transplantation|July 28, 2009
CR represents an early index of potential long survival in multiple myelomaM Wang, K Delasalle, L Feng, et al.
Bone Marrow Transplantation|May 11, 2004
CD8+ cell depletion of donor lymphocyte infusions using cd8 monoclonal antibody-coated high-density microparticles (CD8-HDM) after allogeneic hematopoietic stem cell transplantation: a pilot studyE P Alyea, C Canning, D Neuberg, et al.
British Journal of Haematology|September 30, 1998
Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow TransplantJ Bladé, D Samson, D Reece, et al.
Bone Marrow Transplantation|February 22, 2005
Outcome of unrelated transplants in patients with multiple myelomaK K Ballen, R King, M Carston, et al.
Bone Marrow Transplantation|March 2, 1997
Usefulness of detection of minimal residual disease by 'hypermetaphase' fluorescent in situ hybridization after allogeneic BMT for chronic myelogenous leukemiaD Seong, S Giralt, H Fischer, et al.
Pageof 18